Efficacy and Safety of Subcutaneous Secukinumab for Moderate to Severe Chronic Plaque-type Psoriasis for up to 1 Year

Novartis Investigative Site, Riga

Novartis Investigative Site, Taipei

Novartis Investigative Site, New York

Novartis Investigative Site, Tallinn

Novartis Investigative Site, Tallinn

Novartis Investigative Site, Tallinn

Novartis Investigative Site, Mexico City

Novartis Investigative Site, Rochester

Novartis Investigative Site, Duncansville

Novartis Investigative Site, Afula

Novartis Investigative Site, Philadelphia

Novartis Investigative Site, Norfolk

Novartis Investigative Site, Charleston

Novartis Investigative Site, Snellville

Novartis Investigative Site, Boca Raton

Novartis Investigative Site, Birmingham

Novartis Investigative Site, Birmingham

Novartis Investigative Site, Nashville

Novartis Investigative Site, Louisville

Novartis Investigative Site, Louisville

Novartis Investigative Site, Taichung

Novartis Investigative Site, Zapopan

Novartis Investigative Site, Evansville

Novartis Investigative Site, Ann Arbor

Novartis Investigative Site, Ann Arbor

Novartis Investigative Site, Petah Tikva

Novartis Investigative Site, Kaunas

Novartis Investigative Site, Tartu

Novartis Investigative Site, Ramat Gan

Novartis Investigative Site, Monterrey

Novartis Investigative Site, Topeka

Novartis Investigative Site, Omaha

Novartis Investigative Site, Dallas

Novartis Investigative Site, Houston

Novartis Investigative Site, Bryan

Novartis Investigative Site, San Antonio

Novartis Investigative Site, Austin

Novartis Investigative Site, Colorado Springs

Novartis Investigative Site, Salt Lake City

Novartis Investigative Site, Phoenix

Novartis Investigative Site, Los Angeles

Novartis Investigative Site, Pasadena

Novartis Investigative Site, Oceanside

Novartis Investigative Site, San Diego

Novartis Investigative Site, Klaipėda

Novartis Investigative Site, Oregon City

Novartis Investigative Site, Portland

Novartis Investigative Site, Portland

Novartis Investigative Site, Dallas

Novartis Investigative Site, CABA

Novartis Investigative Site, CABA

Novartis Investigative Site, CABA

Novartis Investigative Site, Mendoza

Novartis Investigative Site, Moncton

Novartis Investigative Site, Hamilton

Novartis Investigative Site, Peterborough

Novartis Investigative Site, Waterloo

Novartis Investigative Site, Montreal

Novartis Investigative Site, Barranquilla

Novartis Investigative Site, Barranquilla

Novartis Investigative Site, Bogotá

Novartis Investigative Site, Bucaramanga

Novartis Investigative Site, Taoyuan District

Novartis Investigative Site, Kopavogur

Novartis Investigative Site, Nagoya

Novartis Investigative Site, Fukuoka

Novartis Investigative Site, Kurume

Novartis Investigative Site, Maebashi

Novartis Investigative Site, Asahikawa

Novartis Investigative Site, Sapporo

Novartis Investigative Site, Kobe

Novartis Investigative Site, Inashiki-gun

Novartis Investigative Site, Isehara

Novartis Investigative Site, Kawasaki

Novartis Investigative Site, Sagamihara

Novartis Investigative Site, Bunkyo-ku

Novartis Investigative Site, Chiyoda-ku

Novartis Investigative Site, Minato-ku

Novartis Investigative Site, Shinagawa-ku

Novartis Investigative Site, Shinjuku-ku

Novartis Investigative Site, Shinjuku-ku

Novartis Investigative Site, Kyoto

Novartis Investigative Site, Daugavpils

Novartis Investigative Site, Riga

Novartis Investigative Site, Ventspils

Novartis Investigative Site, Vilnius

Novartis Investigative Site, Vilnius

Novartis Investigative Site, Mexico City